Annual Planning
Samples will be delivered no later than 1 day before the start date of the relevant round. If this is not the case, please contact us.
Section: General Chemistry
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| ACE | |||
| 2025.1 | 2025-01-01 | 2025-06-30 | |
| 2025.2 | 2025-07-01 | 2025-12-31 | |
| AP-isoenzymes | |||
| 2025.1 | 2025-01-01 | 2025-06-29 | |
| 2025.2 | 2025-06-16 | 2025-12-12 | |
| Bile acid salts | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| Bloodgas Parameters | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| Cardiac markers | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| CDT | |||
| 2025.1 | 2025-01-01 | 2025-06-30 | |
| 2025.2 | 2025-07-01 | 2025-12-31 | |
| Clinical Chemistry, blood | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| Clinical Chemistry, urine qualitative | |||
| 2025.1 | 2025-01-29 | 2025-02-04 | |
| 2025.2 | 2025-04-16 | 2025-04-22 | |
| 2025.3 | 2025-08-13 | 2025-08-19 | |
| 2025.4 | 2025-11-05 | 2025-11-11 | |
| Clinical Chemistry, urine quantitative | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| Cystatin C, serum | |||
| 2025.1 | 2025-01-01 | 2025-06-30 | |
| 2025.2 | 2025-07-01 | 2025-12-31 | |
| Ethanol in serum | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| Feces-chemistry | |||
| 2025.1 | 2025-01-01 | 2025-06-30 | |
| 2025.2 | 2025-07-01 | 2025-12-31 | |
| Fructosamin | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| HbA1c | |||
| 2025.1 | 2025-01-01 | 2025-12-27 | |
| HbA1c whole blood | |||
| 2025.1 | 2025-01-22 | 2025-01-24 | |
| 2025.2 | 2025-03-12 | 2025-03-14 | |
| 2025.3 | 2025-05-14 | 2025-05-16 | |
| 2025.4 | 2025-07-09 | 2025-07-11 | |
| 2025.5 | 2025-09-10 | 2025-09-12 | |
| 2025.6 | 2025-10-22 | 2025-10-24 | |
| Hemoximetry | |||
| 2025.1 | 2025-01-01 | 2025-06-30 | |
| 2025.2 | 2025-07-01 | 2025-12-31 | |
| Homocystein | |||
| 2025.1 | 2025-01-01 | 2025-06-30 | |
| 2025.2 | 2025-07-01 | 2025-12-31 | |
| Inflammation markers | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| Lipids | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| Neonatal Bilirubin | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| Occult blood in feces | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| POCT in whole blood | |||
| 2025.1 | 2025-01-29 | 2025-02-04 | |
| 2025.2 | 2025-04-16 | 2025-04-22 | |
| 2025.3 | 2025-08-13 | 2025-08-19 | |
| 2025.4 | 2025-11-05 | 2025-11-11 | |
| Porphyrines in urine | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-03-31 | 2025-06-28 | |
| 2025.3 | 2025-06-30 | 2025-09-27 | |
| 2025.4 | 2025-09-29 | 2025-12-27 | |
| Trace Elements Serum | |||
| 2025.1 | 2025-04-01 | 2026-03-31 | |
| Trace Elements Urine | |||
| 2025.1 | 2025-04-01 | 2026-03-31 | |
| Trace Elements Whole blood | |||
| 2025.1 | 2025-04-01 | 2026-03-31 | |
| Urine sediment (qualitative) | |||
| 2025.1 | 2025-03-20 | 2025-04-18 | |
| 2025.2 | 2025-05-28 | 2025-06-26 | |
| 2025.3 | 2025-08-28 | 2025-09-26 | |
| 2025.4 | 2025-11-27 | 2025-12-26 | |
| Vitamin A/E and beta-carotene | |||
| 2025.1 | 2025-01-01 | 2025-06-30 | |
| 2025.2 | 2025-07-01 | 2025-12-31 | |
| Vitamin B1/B6 | |||
| 2025.1 | 2025-01-01 | 2025-06-30 | |
| 2025.2 | 2025-07-01 | 2025-12-31 |
Section: Bacteriology / Mycology
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| Bacteriology | |||
| 2025.1 | 2025-01-28 | 2025-02-18 | |
| 2025.2 | 2025-04-01 | 2025-04-22 | |
| 2025.3 | 2025-05-13 | 2025-06-03 | |
| 2025.4 | 2025-09-30 | 2025-10-21 | |
| 2025.5 | 2025-11-18 | 2025-12-09 | |
| Mycobacteriology | |||
| 2025.1 | 2025-09-16 | 2025-12-17 | |
| Mycology | |||
| 2025.1 | 2025-03-10 | 2025-05-10 | |
| 2025.2 | 2025-09-23 | 2025-11-23 |
Section: Endocrinology
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| Hormones in Saliva | |||
| 2025.1 | 2025-01-01 | 2025-02-28 | |
| 2025.2 | 2025-03-01 | 2025-04-30 | |
| 2025.3 | 2025-05-01 | 2025-06-30 | |
| 2025.4 | 2025-07-01 | 2025-08-31 | |
| 2025.5 | 2025-09-01 | 2025-10-31 | |
| 2025.6 | 2025-11-01 | 2025-12-31 | |
| Hormones in Serum | |||
| 2025.1 | 2025-01-01 | 2025-02-28 | |
| 2025.2 | 2025-03-01 | 2025-04-30 | |
| 2025.3 | 2025-05-01 | 2025-06-30 | |
| 2025.4 | 2025-07-01 | 2025-08-31 | |
| 2025.5 | 2025-09-01 | 2025-10-31 | |
| 2025.6 | 2025-11-01 | 2025-12-31 | |
| Hormones in Urine | |||
| 2025.1 | 2025-01-01 | 2025-02-28 | |
| 2025.2 | 2025-03-01 | 2025-04-30 | |
| 2025.3 | 2025-05-01 | 2025-06-30 | |
| 2025.4 | 2025-07-01 | 2025-08-31 | |
| 2025.5 | 2025-09-01 | 2025-10-31 | |
| 2025.6 | 2025-11-01 | 2025-12-31 | |
| Tumor markers | |||
| 2025.1 | 2025-01-01 | 2025-02-28 | |
| 2025.2 | 2025-03-01 | 2025-04-30 | |
| 2025.3 | 2025-05-01 | 2025-06-30 | |
| 2025.4 | 2025-07-01 | 2025-08-31 | |
| 2025.5 | 2025-09-01 | 2025-10-31 | |
| 2025.6 | 2025-11-01 | 2025-12-31 |
Section: Drug analysis and toxicology (KKGT)
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| Alcohols/GHB | |||
| 2025.1 | 2025-02-12 | 2025-03-20 | |
| 2025.2 | 2025-05-07 | 2025-06-12 | |
| 2025.3 | 2025-08-13 | 2025-09-18 | |
| 2025.4 | 2025-10-22 | 2025-11-27 | |
| Analgesic drugs | |||
| 2025.1 | 2025-02-12 | 2025-03-13 | |
| 2025.2 | 2025-05-07 | 2025-06-05 | |
| 2025.3 | 2025-08-13 | 2025-09-11 | |
| 2025.4 | 2025-10-22 | 2025-11-20 | |
| Antibiotic drugs | |||
| 2025.1 | 2025-02-12 | 2025-03-06 | |
| 2025.2 | 2025-05-07 | 2025-05-29 | |
| 2025.3 | 2025-08-13 | 2025-09-04 | |
| 2025.4 | 2025-10-22 | 2025-11-13 | |
| Antibiotic drugs 2 | |||
| 2025.1 | 2025-04-16 | 2025-06-26 | |
| 2025.2 | 2025-09-24 | 2025-12-04 | |
| Antiepileptic drugs | |||
| 2025.1 | 2025-02-12 | 2025-03-06 | |
| 2025.2 | 2025-05-07 | 2025-05-29 | |
| 2025.3 | 2025-08-13 | 2025-09-04 | |
| 2025.4 | 2025-10-22 | 2025-11-13 | |
| Antiepileptic drugs free concentration | |||
| 2025.1 | 2025-02-12 | 2025-03-06 | |
| 2025.2 | 2025-05-07 | 2025-05-29 | |
| 2025.3 | 2025-08-13 | 2025-09-04 | |
| 2025.4 | 2025-10-22 | 2025-11-13 | |
| Antifungal drugs | |||
| 2025.1 | 2025-03-24 | 2025-05-13 | |
| 2025.2 | 2025-06-25 | 2025-08-14 | |
| 2025.3 | 2025-07-16 | 2025-09-04 | |
| 2025.4 | 2025-10-22 | 2025-12-11 | |
| Antiretroviral drugs | |||
| 2025.1 | 2025-04-21 | 2025-06-10 | |
| 2025.2 | 2025-06-25 | 2025-08-14 | |
| 2025.3 | 2025-08-13 | 2025-10-02 | |
| 2025.4 | 2025-10-22 | 2025-12-11 | |
| Antituberculosis drugs | |||
| 2025.1 | 2025-04-16 | 2025-06-26 | |
| 2025.2 | 2025-09-24 | 2025-12-04 | |
| Antiviral drugs | |||
| 2025.1 | 2025-03-26 | 2025-05-23 | |
| 2025.2 | 2025-08-13 | 2025-10-10 | |
| Benzodiazepines | |||
| 2025.1 | 2025-02-12 | 2025-03-13 | |
| 2025.2 | 2025-05-07 | 2025-06-05 | |
| 2025.3 | 2025-08-13 | 2025-09-11 | |
| 2025.4 | 2025-10-22 | 2025-11-20 | |
| Biologicals | |||
| 2025.1 | 2025-03-26 | 2025-05-13 | |
| 2025.2 | 2025-06-25 | 2025-08-12 | |
| 2025.3 | 2025-08-13 | 2025-09-30 | |
| 2025.4 | 2025-10-22 | 2025-12-09 | |
| Busulfan | |||
| 2025.1 | 2025-06-06 | 2025-07-07 | |
| 2025.2 | 2025-11-10 | 2025-12-11 | |
| Cardiac drugs | |||
| 2025.1 | 2025-02-12 | 2025-03-06 | |
| 2025.2 | 2025-05-07 | 2025-05-29 | |
| 2025.3 | 2025-08-13 | 2025-09-04 | |
| 2025.4 | 2025-10-22 | 2025-11-13 | |
| Drugs alternating | |||
| 2025.1 | 2025-02-12 | 2025-03-13 | |
| 2025.2 | 2025-05-07 | 2025-06-05 | |
| 2025.3 | 2025-08-13 | 2025-09-11 | |
| 2025.4 | 2025-10-22 | 2025-11-20 | |
| Drugs of Abuse | |||
| 2025.1 | 2025-02-12 | 2025-03-20 | |
| 2025.2 | 2025-05-07 | 2025-06-12 | |
| 2025.3 | 2025-08-13 | 2025-09-18 | |
| 2025.4 | 2025-10-22 | 2025-11-27 | |
| Immunosuppressant microsampling | |||
| 2025.1 | 2025-03-18 | 2025-04-14 | |
| 2025.2 | 2025-09-03 | 2025-09-30 | |
| Oral oncolytics | |||
| 2025.1 | 2025-03-26 | 2025-04-26 | |
| 2025.2 | 2025-06-25 | 2025-07-26 | |
| 2025.3 | 2025-08-13 | 2025-09-13 | |
| 2025.4 | 2025-10-22 | 2025-11-22 | |
| Psychotherapeutic drugs | |||
| 2025.1 | 2025-02-12 | 2025-03-13 | |
| 2025.2 | 2025-05-07 | 2025-06-05 | |
| 2025.3 | 2025-08-13 | 2025-09-11 | |
| 2025.4 | 2025-10-22 | 2025-11-20 | |
| Thiopurines | |||
| 2025.1 | 2025-03-12 | 2025-04-10 | |
| 2025.2 | 2025-05-21 | 2025-06-19 | |
| 2025.3 | 2025-08-13 | 2025-09-11 | |
| 2025.4 | 2025-10-22 | 2025-11-20 | |
| Toxicology | |||
| 2025.1 | 2025-02-12 | 2025-03-20 | |
| 2025.2 | 2025-05-15 | 2025-06-20 | |
| 2025.3 | 2025-08-13 | 2025-09-18 | |
| 2025.4 | 2025-10-22 | 2025-11-27 |
Section: Hematology
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| Blood Cell Morphology | |||
| 2025.1 | 2025-03-12 | 2025-03-25 | |
| 2025.2 | 2025-06-04 | 2025-06-17 | |
| 2025.3 | 2025-10-08 | 2025-10-21 | |
| Erythrocyte serology basic | |||
| 2025.1 | 2025-01-22 | 2025-02-03 | |
| 2025.2 | 2025-04-02 | 2025-04-14 | |
| 2025.3 | 2025-09-10 | 2025-09-22 | |
| Erythrocyte serology detailed | |||
| 2025.1 | 2025-06-03 | 2025-06-15 | |
| 2025.2 | 2025-10-06 | 2025-10-18 | |
| Erythrocyte serology pregnancy | |||
| 2025.1 | 2025-03-12 | 2025-03-24 | |
| 2025.2 | 2025-06-18 | 2025-06-30 | |
| 2025.3 | 2025-11-12 | 2025-11-24 | |
| Hb variants | |||
| 2025.1 | 2025-01-01 | 2025-07-01 | |
| 2025.2 | 2025-06-16 | 2025-12-14 | |
| Hemocytometry | |||
| 2025.1 | 2025-01-16 | 2025-01-16 | |
| 2025.2 | 2025-03-13 | 2025-03-13 | |
| 2025.3 | 2025-05-01 | 2025-05-01 | |
| 2025.4 | 2025-06-12 | 2025-06-12 | |
| 2025.5 | 2025-09-11 | 2025-09-11 | |
| 2025.6 | 2025-11-13 | 2025-11-13 |
Section: Humoral immunology
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| Allergy | |||
| 2025.1 | 2025-01-14 | 2025-03-04 | |
| 2025.2 | 2025-03-05 | 2025-05-06 | |
| 2025.3 | 2025-05-07 | 2025-08-12 | |
| 2025.4 | 2025-08-13 | 2025-10-28 | |
| Allergy Type III antibodies | |||
| 2025.1 | 2025-10-08 | 2025-11-07 | |
| ANCA-GBM | |||
| 2025.1 | 2025-03-11 | 2025-05-13 | |
| 2025.2 | 2025-09-16 | 2025-11-18 | |
| Antibodies against skin | |||
| 2025.1 | 2025-09-16 | 2025-10-29 | |
| Blood pigments in cerebrospinal fluid | |||
| 2025.1 | 2025-03-12 | 2025-04-18 | |
| 2025.2 | 2025-09-17 | 2025-10-24 | |
| Celiac disease | |||
| 2025.1 | 2025-05-15 | 2025-07-10 | |
| 2025.2 | 2025-10-23 | 2025-12-18 | |
| Collagen | |||
| 2025.1 | 2025-02-14 | 2025-03-16 | |
| 2025.2 | 2025-08-13 | 2025-09-12 | |
| Complement factors | |||
| 2025.1 | 2025-10-13 | 2025-12-08 | |
| Diabetes | |||
| 2025.1 | 2025-09-10 | 2025-11-10 | |
| Liquor protein | |||
| 2025.1 | 2025-03-12 | 2025-04-18 | |
| 2025.2 | 2025-09-17 | 2025-10-24 | |
| M-protein | |||
| 2025.1 | 2025-01-16 | 2025-03-11 | |
| 2025.2 | 2025-04-10 | 2025-06-03 | |
| 2025.3 | 2025-06-26 | 2025-08-19 | |
| 2025.4 | 2025-09-25 | 2025-11-18 | |
| PLA2R antibodies | |||
| 2025.1 | 2025-04-08 | 2025-05-19 | |
| 2025.2 | 2025-10-07 | 2025-11-17 | |
| Plasma proteins | |||
| 2025.1 | 2025-01-01 | 2025-03-31 | |
| 2025.2 | 2025-04-01 | 2025-06-30 | |
| 2025.3 | 2025-07-01 | 2025-09-30 | |
| 2025.4 | 2025-10-01 | 2025-12-31 | |
| Rheuma | |||
| 2025.1 | 2025-04-14 | 2025-05-14 | |
| 2025.2 | 2025-10-13 | 2025-11-12 | |
| Soluble IL2 receptor | |||
| 2025.1 | 2025-05-28 | 2025-06-27 | |
| 2025.2 | 2025-10-29 | 2025-11-28 | |
| Stomach / Liver antibodies | |||
| 2025.1 | 2025-10-08 | 2025-12-10 | |
| Thyroid Antibodies | |||
| 2025.1 | 2025-04-16 | 2025-06-18 | |
| Tryptase | |||
| 2025.1 | 2025-10-08 | 2025-11-06 |
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| BCR::ABL1 and AML Translocation Identification | |||
| 2025.1 | 2025-04-01 | 2025-04-30 | |
| 2025.2 | 2025-08-01 | 2025-08-30 | |
| 2025.3 | 2025-12-01 | 2025-12-30 | |
| BCR::ABL1 Kinase Domain Variant (Mutation) Status | |||
| 2024.3 | 2025-03-05 | 2025-04-03 | |
| 2025.1 | 2025-07-01 | 2025-07-30 | |
| 2025.2 | 2025-10-01 | 2025-10-30 | |
| BCR::ABL1 Major Quantification | |||
| 2024.3 | 2025-02-05 | 2025-03-06 | |
| 2025.1 | 2025-05-01 | 2025-05-30 | |
| 2025.2 | 2025-09-01 | 2025-09-30 | |
| BCR::ABL1 Minor Quantification | |||
| 2024.3 | 2025-01-31 | 2025-03-01 | |
| 2025.1 | 2025-06-01 | 2025-06-30 | |
| 2025.2 | 2025-09-01 | 2025-09-30 | |
| Bonemarrow morphology | |||
| 2025.1 | 2025-04-14 | 2025-05-28 | |
| 2025.2 | 2025-10-13 | 2025-11-26 | |
| CD34 | |||
| 2024.5 | 2025-01-22 | 2025-02-09 | |
| 2024.6 | 2025-02-01 | 2025-02-14 | |
| 2025.1 | 2025-05-01 | 2025-05-14 | |
| 2025.2 | 2025-07-01 | 2025-07-14 | |
| 2025.3 | 2025-09-01 | 2025-09-14 | |
| 2025.4 | 2025-10-01 | 2025-10-14 | |
| 2025.5 | 2025-12-01 | 2025-12-14 | |
| Chimerism | |||
| 2025.1 | 2025-01-06 | 2025-01-31 | |
| Fetomaternal transfusion | |||
| 2025.1 | 2025-03-11 | 2025-03-18 | |
| 2025.2 | 2025-09-16 | 2025-09-23 | |
| Leukemia/Lymphoma typing | |||
| 2025.2 | 2025-06-04 | 2025-06-17 | |
| 2025.3 | 2025-09-09 | 2025-09-22 | |
| 2025.4 | 2025-11-14 | 2025-11-27 | |
| Lymphocyte subsets BAL | |||
| 2025.1 | 2025-08-06 | 2025-08-20 | |
| 2025.2 | 2025-10-30 | 2025-11-13 | |
| Lymphocytes Subsets | |||
| 2024.5 | 2025-01-30 | 2025-02-17 | |
| 2024.6 | 2025-03-01 | 2025-03-14 | |
| 2025.1 | 2025-06-01 | 2025-06-14 | |
| 2025.2 | 2025-08-01 | 2025-08-14 | |
| 2025.3 | 2025-09-01 | 2025-09-14 | |
| 2025.4 | 2025-11-01 | 2025-11-14 | |
| Measurable Residual Disease for AML by Mol. Meth. | |||
| 2024.2 | 2025-03-01 | 2025-03-31 | |
| 2025.1 | 2025-08-01 | 2025-08-31 | |
| MPN molecular diagnostics | |||
| 2025.1 | 2025-04-08 | 2025-05-07 | |
| Mutation screening and NGS in hemat. malignancy | |||
| 2025.1 | 2025-09-02 | 2025-09-22 | |
| PNH diagnostics | |||
| 2025.1 | 2025-03-19 | 2025-04-01 | |
| 2025.2 | 2025-06-25 | 2025-07-08 | |
| 2025.3 | 2025-09-16 | 2025-09-29 |
Section: Infection serology
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| anti-HBc screen | |||
| 2025.1 | 2025-01-01 | 2025-03-11 | |
| 2025.2 | 2025-03-12 | 2025-06-11 | |
| 2025.3 | 2025-06-12 | 2025-09-11 | |
| anti-HBs screen | |||
| 2025.1 | 2025-01-01 | 2025-03-11 | |
| 2025.2 | 2025-03-12 | 2025-06-11 | |
| 2025.3 | 2025-06-12 | 2025-09-11 | |
| AST / AntiDNaseB serology | |||
| 2025.1 | 2025-06-11 | 2025-07-01 | |
| Bartonella henselae serology | |||
| 2025.1 | 2025-05-14 | 2025-06-03 | |
| Bordetella serology | |||
| 2025.1 | 2025-09-24 | 2025-10-14 | |
| Brucella serology | |||
| 2025.1 | 2025-08-25 | 2025-09-14 | |
| CMV/EBV/Toxoplasma serology | |||
| 2025.1 | 2025-03-12 | 2025-03-25 | |
| 2025.2 | 2025-10-17 | 2025-10-30 | |
| Exantheme Diseases Diagnostics | |||
| 2025.1 | 2025-01-29 | 2025-02-18 | |
| HBsAg screen | |||
| 2025.1 | 2025-01-01 | 2025-03-11 | |
| 2025.2 | 2025-03-12 | 2025-06-11 | |
| 2025.3 | 2025-06-12 | 2025-09-11 | |
| HCV screen | |||
| 2025.1 | 2025-01-01 | 2025-03-11 | |
| 2025.2 | 2025-03-12 | 2025-06-11 | |
| 2025.3 | 2025-06-12 | 2025-09-11 | |
| Helicobacter pylori (Ag) in feces | |||
| 2025.1 | 2025-09-10 | 2025-09-30 | |
| Helicobacter serology | |||
| 2025.1 | 2025-03-26 | 2025-04-15 | |
| Hepatitis ABCE serology | |||
| 2025.1 | 2025-05-14 | 2025-06-03 | |
| 2025.2 | 2025-11-19 | 2025-12-09 | |
| HIV screen | |||
| 2025.1 | 2025-01-01 | 2025-03-11 | |
| 2025.2 | 2025-03-12 | 2025-06-11 | |
| 2025.3 | 2025-06-12 | 2025-09-11 | |
| HIV serology (incl. blot) | |||
| 2025.1 | 2025-05-21 | 2025-06-10 | |
| HTLV-I screen | |||
| 2025.1 | 2025-01-01 | 2025-03-11 | |
| 2025.2 | 2025-03-12 | 2025-06-11 | |
| 2025.3 | 2025-06-12 | 2025-09-11 | |
| Immunity serology | |||
| 2025.1 | 2025-07-16 | 2025-08-05 | |
| Lues / Lyme serology | |||
| 2025.1 | 2025-05-14 | 2025-06-03 | |
| 2025.2 | 2025-11-26 | 2025-12-16 | |
| Lues screen (TPHA) | |||
| 2025.1 | 2025-01-01 | 2025-03-11 | |
| 2025.2 | 2025-03-12 | 2025-06-11 | |
| 2025.3 | 2025-06-12 | 2025-09-11 | |
| Respiratory serology | |||
| 2025.1 | 2025-10-15 | 2025-11-04 |
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| Molecular Biology various | |||
| 2025.1 | 2025-03-12 | 2025-04-18 | |
| 2025.2 | 2025-09-09 | 2025-10-16 | |
| Pharmacogenetics | |||
| 2025.1 | 2025-03-12 | 2025-04-18 | |
| 2025.2 | 2025-09-09 | 2025-10-16 | |
| Thrombophilia (genetics) | |||
| 2025.1 | 2025-03-12 | 2025-04-18 | |
| 2025.2 | 2025-09-09 | 2025-10-16 |
Section: Parasitology
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| Acanthamoeba Extern. Mol. Quality Assessment | |||
| 2025.1 | 2025-06-03 | 2025-07-20 | |
| Blood parasites | |||
| 2025.1 | 2025-03-04 | 2025-03-30 | |
| 2025.2 | 2025-05-20 | 2025-06-15 | |
| 2025.3 | 2025-09-09 | 2025-10-05 | |
| 2025.4 | 2025-11-18 | 2025-12-14 | |
| Helminth External Mol. Quality Assessment | |||
| 2025.1 | 2025-09-16 | 2025-12-07 | |
| Intestinal protozoa Molecular Diagnostics | |||
| 2025.1 | 2025-02-25 | 2025-03-23 | |
| 2025.2 | 2025-04-29 | 2025-05-18 | |
| 2025.3 | 2025-11-11 | 2025-12-07 | |
| Intestinal-, tissue and ecto parasites | |||
| 2025.1 | 2025-03-04 | 2025-03-30 | |
| 2025.2 | 2025-05-20 | 2025-06-15 | |
| 2025.3 | 2025-09-09 | 2025-10-05 | |
| 2025.4 | 2025-11-18 | 2025-12-14 | |
| STD External Molecular Quality Assessment Scheme | |||
| 2025.1 | 2025-04-29 | 2025-05-18 | |
| 2025.2 | 2025-11-11 | 2025-12-07 |
Section: Semen
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| Semen analysis | |||
| 2025.1 | 2025-02-21 | 2025-03-19 | |
| 2025.2 | 2025-05-09 | 2025-06-04 | |
| 2025.3 | 2025-08-29 | 2025-09-24 | |
| 2025.4 | 2025-10-31 | 2025-11-26 |
Section: Coagulation
| Scheme | Round | Start date | Submit ultimately (23:59 CET) |
|---|---|---|---|
| Coagulation | |||
| 2025.1 | 2025-02-03 | 2025-02-07 | |
| 2025.2 | 2025-03-24 | 2025-03-28 | |
| 2025.3 | 2025-05-05 | 2025-05-09 | |
| 2025.4 | 2025-06-30 | 2025-07-04 | |
| 2025.5 | 2025-09-01 | 2025-09-05 | |
| 2025.6 | 2025-11-03 | 2025-11-07 | |
| D-Dimer | |||
| 2025.1 | 2025-03-18 | 2025-04-01 | |
| 2025.2 | 2025-06-03 | 2025-06-17 | |
| 2025.3 | 2025-08-19 | 2025-09-02 | |
| 2025.4 | 2025-11-11 | 2025-11-25 | |
| PT-INR for oral anticoagulation | |||
| 2025.1 | 2025-02-03 | 2025-02-07 | |
| 2025.2 | 2025-03-24 | 2025-03-28 | |
| 2025.3 | 2025-05-05 | 2025-05-09 | |
| 2025.4 | 2025-06-30 | 2025-07-04 | |
| 2025.5 | 2025-09-01 | 2025-09-05 | |
| 2025.6 | 2025-11-03 | 2025-11-07 |